Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy

Journal of Experimental Medicine

Volumn 184, Issue 2, 1996, Pages 609-618

  Chao, Daniel S ^a   Gorospe, J Rafael M ^b   Brenman, Jay E ^a   Rafael, Jill A ^c   Peters, Matthew F ^d   Froehner, Stanley C ^d   Hoffman, Eric P ^b   Chamberlain, Jeffrey S ^c   Bredt, David S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; NITRIC OXIDE SYNTHASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BECKER MUSCULAR DYSTROPHY; CONTROLLED STUDY; ENZYME SYNTHESIS; MOUSE; MUSCLE FIBER MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; SARCOLEMMA;

EID: 0029835575     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.2.609     Document Type: Article

References (43)

1. Engel, A.G., and B.Q. Banker. 1994. Myology: Basic and Clinical. McGraw-Hill Inc., New York. 215a pp.
2. Hoffman, E.P. 1993. Genotype/Phenotype Correlations in Duchenne/Becker Muscular Dystrophy. Mol. Cell Biol. Hum. Dis. 3:12-36.
3. Hoffman, E.P., K.H. Fischbeck, R.H. Brown, M. Johnson, R. Medori, J.D. Loike, J.B. Harris, R. Waterston, M. Brooke, L. Specht et al. 1988. Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N. Engl. J. Med. 318:1363-1368.
4. Beggs, A.H., E.P. Hoffman, J.R. Snyder, K. Arahata, L. Specht, F. Shapiro, C. Angelini, H. Sugita, and L.M. Kunkel. 1991. Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. Am. J. Hum. Genet. 49:54-67.
5. Arahata, K., E.P. Hoffman, L.M. Kunkel, S. Ishiura, T. Tsukahara, T. Ishihara, N. Sunohara, I. Nonaka, E. Ozawa, and H. Sugita. 1989. Dystrophin diagnosis: comparison of dystrophin abnormalities by immunofluorescence and immunoblot analyses. Proc. Natl. Acad. Sci. USA. 86:7154-7158.
6. Koenig, M., A.P. Monaco, and L.M. Kunkel. 1988. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell. 53:219-26.
7. 2-terminal domain of dystrophin in Escherichia coli and demonstration of binding to F-actin. FEBS (Fed. Eur. Biochem. Soc.) Lett. 301:243-245.
8. Cox, G.A., Y. Sunada, K.P. Campbell, and J.S. Chamberlain. 1994. Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fail to prevent dystrophy. Nature Genetics. 8:333-339.
9. Greenberg, D.S., Y. Sunada, K.P. Campbell, D. Yaffe, and U. Nudel. 1994. Exogenous Dp71 restores the levels of dystrophin associated proteins but does not alleviate muscle damage in mdx mice. Nature Genetics. 8:340-344.
10. Suzuki, A., M. Yoshida, K. Hayashi, Y. Mizuno, Y. Hagiwara, and E. Ozawa. 1994. Molecular organization at the glycoprotein-complex-binding site of dystrophin. Three dystrophin-associated proteins bind directly to the carboxy-terminal portion of dystrophin. Eur. J. Biochem. 220:283-292.
11. Adams, M.E., M.H. Butler, T.M. Dwyer, M.F. Peters, A.A. Murnane, and S.C. Froehner. 1993. Two forms of mouse syntrophin, a 58 kd dystrophin-associated protein, differ in primary structure and tissue distribution. Neuron. 11:531-540.
12. Ibraghimov-Beskrovnaya, O., J.M. Ervasti, C.J. Leveille, C.A. Slaughter, S.W. Sernett, and K.P. Campbell. 1992. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature (Lond.). 355: 696-702.
13. Ervasti, J.M., K. Ohlendieck, S.D. Kahl, M.G. Gaver, and K.P. Campbell. 1990. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature (Lond.). 345:315-319.
14. Ervasti, J.M., and K.P. Campbell. 1993. Dystrophin and the membrane skeleton. Curr. Opin. Cell. Biol. 5:82-87.
15. Bonnemann, C.G., R. Modi, S. Noguchi, Y. Mizuno, M. Yoshida, E. Gussoni, E.M. McNally, D.J. Duggan, G. Angelini, E.P. Hoffman et al. 1995. Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nature Genetics 11:266-273.
16. Lim, L.E., F. Duclos, O. Broux, N. Bourg, Y. Sunada, V. Allamand, J. Meyer, I. Richard, C. Moomaw, C. Slaughter et al. 1995. Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nature Genetics. 11: 257-265.
17. Noguchi, S., E.M. McNally, K. Ben Othmane, Y. Hagiwara, Y. Mizuno, M. Yoshida, H. Yamamoto, C.G. Bonnemann, E. Gussoni, P.H. Denton et al. 1995. Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy [see comments]. Science (Wash. DC). 270:819-822.
18. Roberds, S.L., F. Leturcq, V. Allamand, F. Piccolo, M. Jeanpierre, R.D. Anderson, L.E. Lim, J.C. Lee, F.M. Tome, N.B. Romero, et al. 1994. Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell. 78:625-633.
19. Cox, G.A., N.M. Cole, K. Matsumura, S.F. Phelps, S.D. Hauschka, K.P. Campbell, J.A. Faulkner, and J.S. Chamberlain. 1993. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity [see comments]. Nature (Lond.). 364:725-729.
20. Phelps, S.F., M.A. Hauser, N.M. Cole, J.A. Rafael, R.T. Hinkle, J.A. Faulkner, and J.S. Chamberlain. 1995. Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice. Hum. Mol. Genet. 4:1251-1258.
21. Wells, D.J., K.E. Wells, E.A. Asante, G. Turner, Y. Sunada, K.P. Campbell, F.S. Walsh, and G. Dickson. 1995. Expression of human full-length and minidystrophin in transgenic mdx mice: implications for gene therapy of Duchenne muscular dystrophy. Hum. Mol. Genet. 4:1245-1250.
22. Campanelli, J.T., S.L. Roberds, K.P. Campbell, and R.H. Scheller. 1994. A role for dystrophin-associated glycoproteins and utrophin in agrin-induced AChR clustering. Cell. 77: 663-674.
23. Gee, S.H., F. Montanaro, M.H. Lindenbaum, and S. Carbonetto. 1994. Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor. Cell. 77:675-686.
24. Lee, K.H., M.Y. Baek, K.Y. Moon, W.K. Song, C.H. Chung, D.B. Ha, and M.S. Kang. 1994. Nitric oxide as a messenger molecule for myoblast fusion. J. Biol. Chem. 269: 14371-14374.
25. Wang, T., Z. Xie, and B. Lu. 1995. Nitric oxide mediates activity-dependent synaptic suppression at developing neuromuscular synapses. Nature (Lond.). 374:262-266.
26. Kobzik, L., M.B. Reid, D.S. Bredt, and J.S. Stamler. 1994. Nitric oxide in skeletal muscle. Nature (Lond.). 372:546-548.
27. Grozkanovic, Z., G. Nakos, G. Dahramann, B. Mayer, and R. Gossrau. 1995. Species-independent expression of nitric oxide synthase in the sarcolemma region of visceral and somatic striated muscle fibers. Cell Tissue Res. 281:493-499.
28. Brenman, J.E., D.S. Chao, H. Xia, K. Aldape, and D.S. Bredt. 1995. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell. 82:743-752.
29. Brenman, J.E., D.S. Chao, S.H. Gee, A.W. McGee, S.E. Craven, D.R. Santillano, F. Huang, H. Xia, M.F. Peters, S.C. Froehner, and D.S. Bredt. 1996. Interaction of nitric oxide synthase with the synaptic density protein PSD-95 and α-1 syntrophin mediated by PDZ motifs. Cell. 84:757-767.
30. Bredt, D.S., P.M. Hwang, and S.H. Snyder. 1990. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature (Lond.). 347:768-770.
31. Peters, M.F., N.R. Kramarcy, R. Sealock, and S.C. Froehner. 1994. Beta 2-Syntrophin: localization at the neuromuscular junction in skeletal muscle. Neuroreport. 5:1577-1580.
32. Hoffman, E.P., L.M. Kunkel, C. Angelini, A. Clarke, M. Johnson, and J.B. Harris. 1989. Improved diagnosis of Becker muscular dystrophy by dystrophin testing. Neurology. 39: 1011-1017.
33. Hoffman, E.P., J.E. Morgan, S.C. Watkins, and T.A. Partridge. 1990. Somatic reversion/suppression of the mouse mdx phenotype in vivo. J. Neurol. Sci. 99:9-25.
34. Duggan, D.J., M. Fanin, E. Pegoraro, C. Angelini, and E.P. Hoffman. 1996. Adhalinopathies: complete biochemical deficiency patients are 5% of childhood-onset dystrophin-normal muscular dystrophy and most partial deficiency patients do not have gene mutations. J. Neurol. Sci. In press.
35. Rafael, J.A., Y. Sunada, N.M. Cole, K.P. Campbell, J.A. Faulkner, and J.S. Chamberlain. 1994. Prevention of dystrophic pathology in mdx mice by a truncated dystrophin isoform. Hum. Mol. Genet. 3:1725-1733.
36. Yang, B., O. Ibraghimov-Beskrovnaya, C.R. Moomaw, C.A. Slaughter, and K.P. Campbell. 1994. Heterogeneity of the 59-kDa dystrophin-associated protein revealed by cDNA cloning and expression. J. Biol. Chem. 269:6040-6044.
37. Ervasti, J.M., S.D. Kahl, and K.P. Campbell. 1991. Purification of dystrophin from skeletal muscle. J. Biol. Chem. 266: 9161-9165.
38. Adams, M.E., T.M. Dwyer, L.L. Dowler, R.A. White, and S.C. Froehner. 1995. Mouse α1- and β2-syntrophin gene structure, chromosome localization, and homology with a discs large domain. J. Biol. Chem. 270:25859-25865.
39. Ahn, A.H., and L.M. Kunkel. 1995. Syntrophin binds to an alternatively spliced exon of dystrophin. J. Cell Biol. 128:363-371.
40. Suzuki, A., M. Yoshida, and E. Ozawa. 1995. Mammalian alpha 1- and beta 1-syntrophin bind to the alternative splice-prone region of the dystrophin COOH terminus. J. Cell. Biol. 128:373-381.
41. Yang, B., D. Jung, J.A. Rafael, J.S. Chamberlain, and K.P. Campbell. 1995. Identification of alpha-syntrophin binding to syntrophin triplet, dystrophin, and utrophin. J. Biol. Chem. 270:4975-4978.
42. Inglese, J., W.J. Koch, K. Touhara, and R.J. Lefkowitz. 1995. G beta gamma interactions with PH domains and Ras-MAPK signaling pathways. Trends Biochem. Sci. 20:151-156.
43. England, S.B., L.V. Nicholson, M.A. Johnson, S.M. Forrest, D.R. Love, E.E. Zubrzycka-Gaarn, D.E. Bulman, J.B. Harris, and K.E. Davies. 1990. Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature (Loud.). 343:180-182.